Skip to content

Apotheek Dampoort: what changed

BE 0429.379.012NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€25,538
2024 · €12,692+€12,846
Equity
€196,779
2024 · €197,241-€462
Cash
€123,055
2024 · €93,751+€29,304
Balance sheet total
€357,644
2024 · €325,423+€32,221

Largest movements

2024 to 2025
Assets
  • Cash +€29,304

    up €29,304 (+31.3%), from €93,751 to €123,055

    mainly Other debts (+€27,204) and Net result for the year (+€25,538)

Equity and liabilities
  • Other debts +€27,204

    up €27,204 (+35.0%), from €77,720 to €104,924

  • Trade debts +€8,665

    up €8,665 (+21.5%), from €40,348 to €49,013

Income statement
  • Staff costs -€16,346

    down €16,346 (-26.1%), from €62,702 to €46,356

  • Financial charges -€3,041

    down €3,041 (-22.7%), from €13,369 to €10,328

  • Gross operating margin -€2,231

    down €2,231 (-2.3%), from €95,049 to €92,818

  • Taxes +€2,141

    up €2,141 (+47.3%), from €4,530 to €6,671

  • Depreciation +€1,581

    up €1,581 (+61.2%), from €2,584 to €4,166

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €12,692
Gross operating margin -€2,231
Staff costs +€16,346
Depreciation -€1,581
Other operating charges -€238
Financial income -€349
Financial charges +€3,041
Taxes -€2,141
Result 2025 €25,538
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€56,424
Investment -€1,120
Financing -€26,000
Cash 2024 €93,751
Net result for the year +€25,538
Depreciation +€4,166
Stocks and contracts -€2,295
Receivables within one year -€3,424
Deferred charges and accrued income -€244
Trade debts +€8,665
Tax, wage and social debts -€2,291
Other debts +€27,204
Accrued charges and deferred income -€895
Investment in fixed assets (net) -€1,120
Contributions, distributions and other -€26,000
Cash 2025 €123,055
brings cash intakes cash out
Every line side by side 40 lines
Line Code 2024 2025 Change %
Total assets 20/58 €325,423 €357,644 +€32,221 +9.9%
Fixed assets 21/28 €15,565 €12,519 -€3,046 -19.6%
Tangible fixed assets 22/27 €15,565 €12,519 -€3,046 -19.6%
Land and buildings 22 €6,885 €6,898 +€13 +0.2%
Plant, machinery and equipment 23 €8,680 €5,621 -€3,059 -35.2%
Current assets 29/58 €309,858 €345,125 +€35,267 +11.4%
Stocks and contracts in progress 3 €114,342 €116,637 +€2,295 +2.0%
Stocks 30/36 €114,342 €116,637 +€2,295 +2.0%
Amounts receivable within one year 40/41 €101,690 €105,114 +€3,424 +3.4%
Trade receivables 40 €78,243 €82,853 +€4,610 +5.9%
Other amounts receivable 41 €23,446 €22,261 -€1,185 -5.1%
Cash at bank and in hand 54/58 €93,751 €123,055 +€29,304 +31.3%
Deferred charges and accrued income 490/1 €76 €319 +€244 +322%
Total equity and liabilities 10/49 €325,423 €357,644 +€32,221 +9.9%
Equity 10/15 €197,241 €196,779 -€462 -0.2%
Contributions 10/11 €49,579 €49,579 = 0.0%
Reserves 13 €147,663 €147,201 -€462 -0.3%
Distributable reserves 133 €147,663 €147,201 -€462 -0.3%
Amounts payable 17/49 €128,182 €160,865 +€32,683 +25.5%
Amounts payable within one year 42/48 €127,246 €160,825 +€33,578 +26.4%
Trade debts 44 €40,348 €49,013 +€8,665 +21.5%
Suppliers 440/4 €40,348 €49,013 +€8,665 +21.5%
Taxes, remuneration and social security 45 €9,179 €6,888 -€2,291 -25.0%
Taxes 450/3 - €200 +€200
Remuneration and social security 454/9 €9,179 €6,688 -€2,491 -27.1%
Other amounts payable 47/48 €77,720 €104,924 +€27,204 +35.0%
Accrued charges and deferred income 492/3 €936 €40 -€895 -95.7%
Remuneration, social security and pensions 62 €62,702 €46,356 -€16,346 -26.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €2,584 €4,166 +€1,581 +61.2%
Other operating charges 640/8 €600 €838 +€238 +39.6%
Gross operating margin 9900 €95,049 €92,818 -€2,231 -2.3%
Operating profit (loss) 9901 €29,163 €41,458 +€12,296 +42.2%
Financial income 75/76B €1,429 €1,079 -€349 -24.4%
Recurring financial income 75 €1,429 €1,079 -€349 -24.4%
Financial charges 65/66B €13,369 €10,328 -€3,041 -22.7%
Recurring financial charges 65 €13,369 €10,328 -€3,041 -22.7%
Profit (loss) for the period before taxes 9903 €17,222 €32,209 +€14,987 +87.0%
Income taxes 67/77 €4,530 €6,671 +€2,141 +47.3%
Profit (loss) for the period 9904 €12,692 €25,538 +€12,846 +101%
Profit (loss) for the period to be appropriated 9905 €12,692 €25,538 +€12,846 +101%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€175,304 to €206,070

Midpoint €188,123 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Adjusted equity €196,779
Capitalised earnings €153,829 to €215,360
Indication €175,304 to €206,070

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€196,779
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€196,779

Capitalised earnings

net result for the year (9904)
2025
€25,538
2024
€12,692
2023
€26,379
2022
€23,521
2021
€9,855
Average result
€21,536
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€153,829 / €179,467 / €215,360

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 11 November 2026 via checked.be.